Gene · 7307
Papers3,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PHF6 mutations in chronic myelomonocytic leukemia identify a unique subset of patients with distinct phenotype and superior prognosis. | Am J Hematol | 2024 | 39329442 | PubTator, text mining | PubMed |
| Distinct mutation features and its clinical significance in myelodysplastic syndromes with normal karyotype. | Ann Hematol | 2024 | 39302466 | PubTator, text mining | PubMed |
| Phase I/II study of the clinical activity and safety of GSK3326595 in patients with myeloid neoplasms. | Ther Adv Hematol | 2024 | 39290981 | PubTator, text mining | PubMed |
| Prognostic impact of DTA mutation and co-occurring mutations in patients with myelodysplastic syndrome. | Mol Biol Rep | 2024 | 39278886 | PubTator, text mining | PubMed |
| Long-term longitudinal analysis of 4,187 participants reveals insights into determinants of clonal hematopoiesis. | Nat Commun | 2024 | 39251642 | PubTator, text mining | PubMed |
| Metabolic labeling based methylome profiling enables functional dissection of histidine methylation in C3H1 zinc fingers. | Nat Commun | 2024 | 39198440 | PubTator, text mining | PubMed |
Prognostic mutations identified by whole-exome sequencing and validation of the Molecular International Prognostic Scoring System in myelodysplastic syndromes after allogeneic haematopoietic stem cell transplantation. | Br J Haematol | 2024 | 39138006 | PubTator, text mining | PubMed |
| The clinical implications of BCOR mutations in a large cohort of acute myeloid leukemia patients: a 5-year single-center retrospective study. | Leuk Lymphoma | 2024 | 39126311 | PubTator, text mining | PubMed |
| Influence of genetic co-mutation on chemotherapeutic outcome in NPM1-mutated and FLT3-ITD wild-type AML patients. | Cancer Med | 2024 | 39126219 | PubTator, text mining | PubMed |
| Acute myeloid leukemia with gastric carcinoma: A case report of a double malignancy. | Medicine (Baltimore) | 2024 | 39121277 | PubTator, text mining | PubMed |
| Genomic mutation patterns and prognostic value in de novo and secondary acute myeloid leukemia: A multicenter study from China. | Int J Cancer | 2024 | 39109820 | PubTator, text mining | PubMed |
| Microsatellite instability at U2AF-binding polypyrimidic tract sites perturbs alternative splicing during colorectal cancer initiation. | Genome Biol | 2024 | 39107855 | PubTator, text mining | PubMed |
| A simple method to visualize pre-mRNA splicing with the naked eye using a genetically encoded visual splicing reporter. | Plant Physiol | 2024 | 39056536 | PubTator, text mining | PubMed |
| The role of clonal progression leading to the development of therapy-related myeloid neoplasms. | Ann Hematol | 2024 | 39031199 | PubTator, text mining | PubMed |
| RNA biogenesis and RNA metabolism factors as R-loop suppressors: a hidden role in genome integrity. | Genes Dev | 2024 | 38986581 | PubTator, text mining | PubMed |
| Taxonomy of introns and the evolution of minor introns. | Nucleic Acids Res | 2024 | 38943346 | PubTator, text mining | PubMed |
| Analyzing Differences in Hematological and Immunological Characteristics Related to Common Gene Mutations in Myelodysplastic Syndromes. | Discov Med | 2024 | 38926115 | PubTator, text mining | PubMed |
| Comparative analysis of retroviral Gag-host cell interactions: focus on the nuclear interactome. | Retrovirology | 2024 | 38898526 | PubTator, text mining | PubMed |
| Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms. | Blood Cancer J | 2024 | 38890297 | PubTator, text mining | PubMed |
| Biological relevance of alternative splicing in hematologic malignancies. | Mol Med | 2024 | 38760666 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7307/papers?page=10